Live Breaking News & Updates on Arquer Diagnostics

Stay updated with breaking news from Arquer diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Post-Hoc Analysis Confirms Consistent Clinical Benefit With Olaparib Plus Abiraterone in HRR-Mutated mCRPC

Olaparib plus abiraterone acetate delayed disease progression and improved outcomes in patients with BRCA-, ATM- and CDK12-mutated mCRPC. ....

United States , Bristol Myers Squibb , Bristol Myers Squibb Sanofi , Medivation Astellas , Immunitybio Incyte , Merck Serono , Nonagen Bioscience , Astellas Pharma , Jiangsu Yahong Meditech , Telix Pharmaceuticals , Carolina Urologic Research Center , Asieris Pharmaceuticals , Foundation Medicine , Clarity Pharmaceuticals , Aragon Pharmaceuticals , Speciality Networks , Myovant Sciences , Palette Life Sciences , Guardant Health , Bureau For Astellas Pharma , Platformq Health , Boston Scientific , Janssen Scientific Affairs , Cmt Group , Neal Shore , Genesiscare United States ,

Phase 2 Data Show Clinical Activity With CG0070 Plus Pembrolizumab in NMIBC

Cretostimogene grenadenorepvec in combination with pembrolizumab produced high complete response rates with a tolerable safety profile in patients with Bacillus Calmette-Guérin–unresponsive non–muscle invasive bladder cancer. ....

United States , Urogen Pharma , Roger Li , Moffitt Cancer Center , American Urological Association Annual Meeting , Bacillus Calmette Gu , Urological Association Annual , Arquer Diagnostics , Phase 2 Core 001 Trial , Non Muscle Invasive Bladder Cancer ,

Arquer Diagnostics' ADXBLADDER Becomes First Bladder Cancer Urine Test To Undergo Rigorous Clinical Trials In USA

Arquer Diagnostics ADXBLADDER Becomes First Bladder Cancer Urine Test To Undergo Rigorous Clinical Trials In USA
First patients recruited for bladder cancer recurrence monitoring study
News provided by
Share this article
SUNDERLAND, England, July 27, 2021 /PRNewswire/
ADXBLADDER has become the first new generation urinary biomarker test for bladder cancer to undergo rigorous clinical trials in the USA in decades. The innovative and highly accurate test, developed by UK company Arquer Diagnostics, is already approved for use across Europe.
ADXBLADDER is now being evaluated in a bladder cancer recurrence monitoring study in the US. With results of the study expected by the end of 2021, Arquer Diagnostics hopes to make a 510(k) premarket submission to the US Food and Drug Administration (FDA) to gain clearance from the organisation for ....

United States , United Kingdom , Aashish Kamat , Jacqui Stockley , European Association Of Urology , Oncology Trial Management Organisation , National Cancer Institute Comprehensive Center , Drug Administration , Karmanos Cancer Institute Wayne State University , Md Anderson Cancer Center , Cancer Research , Carolina Urologic Research Centre , American Cancer Society , Arquer Diagnostics , Chief Scientific Officer , Minichromosome Maintenance Complex Component , Uro Oncology Trial Management Organisation , Karmanos Cancer , Wayne State University , European Association , Negative Predictive Value , Positive Predictive Value , Urologic Oncology , Cancer Center , Neal Shore , Medical Director ,

Bladder Cancer Gender Health Gap: Women More Likely To Face Diagnosis Delays Than Men

Survey finds misdiagnosis and delays putting women's lives at risk SUNDERLAND, England, May 6, 2021 /PRNewswire/ Women with bladder cancer symptoms feel ignored by their doctor, face ....

United Kingdom , Nadia Whittley , Prabhakar Rajan , Kostenloser Wertpapierhandel , Lydia Makaroff , Nature Communications , World Bladder Cancer Patient Coalition , Cancer Research United Kingdom , Fight Bladder Cancer , United Kingdom Based , Arquer Diagnostics , Vice President , Minichromosome Maintenance Complex Component , Clinical Senior Lecturer , Queen Mary University , Chief Executive Officer , ஒன்றுபட்டது கிஂக்டம் , நாடியா வ்ீத்டிலெய் , லிடியா மககரோப்ப் , இயற்கை தகவல்தொடர்புகள் , உலகம் சிறுநீர்ப்பை புற்றுநோய் நோயாளி கூட்டணி , புற்றுநோய் ஆராய்ச்சி ஒன்றுபட்டது கிஂக்டம் , சண்டை சிறுநீர்ப்பை புற்றுநோய் , ஒன்றுபட்டது கிஂக்டம் அடிப்படையிலானது , துணை ப்ரெஸிடெஂட் , மருத்துவ மூத்தவர் விரிவுரையாளர் ,

New Hope For Women With Suspected Endometrial Cancer As Arquer Diagnostics' Innovative Urine Test Rules Out Disease In Up To 99% Of Cases

New Hope For Women With Suspected Endometrial Cancer As Arquer Diagnostics' Innovative Urine Test Rules Out Disease In Up To 99% Of Cases
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Nadia Whittley , Richard Edmondson , Manchester University , University Of Manchester , Foundation Trust , Minichromosome Maintenance Complex Component , United Kingdom Based Arquer , Saint Mary , Negative Predictive Value , Chief Executive Officer , Arquer Diagnostics , Endometrial Cancer Pathway , United Kingdom Based , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , நாடியா வ்ீத்டிலெய் , ரிச்சர்ட் எட்மொன்டன் , மான்செஸ்டர் பல்கலைக்கழகம் , பல்கலைக்கழகம் ஆஃப் மான்செஸ்டர் , அடித்தளம் நம்பிக்கை , துறவி மேரி , எதிர்மறை ப்ரிடிக்டிவ் மதிப்பு , தலைமை நிர்வாகி அதிகாரி , ஒன்றுபட்டது கிஂக்டம் அடிப்படையிலானது ,